Page 1 from 2
<<First <Previous Page: 1 2 Next> Last>>
Two more cancer drug-candidates for Bayer Schering Pharma AG
Bayer Schering AG, Germany, acquires the preclinical anti-cancer program from Swiss pharma company Nycomed. Two potential drug candidates are expanding the German oncology Read more …
New drug protects against venous blood clots
In the EU blood clots are responsible for killing 544.000 people each year. Rivaroxaban, a new oral given anticoagulant drug from Bayer Healthcare, is significantly more effective Read more …
Inhaled TB vaccine
USA - A new tuberculosis vaccine successfully tested at the University of North Carolina (UNC) is easier to administer and store and just as effective as one commonly used Read more …
Development of potential Hepatitis C vaccine
The British Midlands’ University of Nottingham discovered a possible vaccine for use in the treatment of Hepatits C. At the 161st. meeting of the Society for General Microbiology Read more …
Insulin capsules – a promising alternative to injections
Researchers from the Robert Gordon University in Aberdeen, UK, presented a study at The British Pharmaceutical Conference, held from 10th to 12th September, 2007, at Manchester Read more …
Diuretic pill extends life
UK & France – The Hypertension in the Very Elderly Trial (HYVET), the biggest global clinical trial to assess the benefits of lowering blood pressure in patients aged 80+, was Read more …
Novartis launched once-a-year osteoporosis treatment
The Swiss company Novartis recently received the FDA approval for the U.S. market for their new osteoporosis drug “Reclast”, a therapy that is only given once a year via a Read more …
Aetiology of glaucoma
A study of european scientists reveals that misfolded amyloid beta proteins, generally regarded as the cause for Alzheimer’s disease, could also cause glaucoma. The scientists Read more …
Transdermal Carrier Technology (TPM): Non-invasive application of insulin
Phosphagenics’ TPM uses natural dermal transport mechanisms to deliver a dose of medication through the skin into the bloodstream. Now a Phase 1b transdermal insulin trial was Read more …
Treating Alzheimer with a skin patch
“Exelon Patch”, developed by Novartis is the first skin patch to treat patients with mild to moderate Alzheimer disease. The new therapy that has already been approved by the FDA, Read more …
Breakthrough in lymphatic cancer treatment
Celebrating his 71st birthday this year, Czech chemist Professor Antonin Holy will also be able to celebrate the launch of clinical testing of a drug to treat non-Hodgkins Read more …
European Parliament opens door for advanced therapies
The European Parliament voted for an EU Regulation on advanced therapies like gene therapy, cell therapy and tissue engineering. The decision, if adopted by the council, could Read more …
A new study could revolutionise drug testing
Researchers have made a breakthrough by detecting the electrical equivalent of a living cell's last gasp. The work takes them a step closer to both seeing the 'heartbeat' of a Read more …
Bless you! The allergy season has begun
The beautiful weather not only causes high spirit but also seasonal allergies. And as every year, over-the-counter allergy medications are booming, whereas most of the patients Read more …
Britain earmarks £50 million for NHS genetics
‘Genetics offers prediction of risk, more precise diagnosis, more targeted and effective use of existing drugs, new gene-based drugs and therapies, and prevention and treatment Read more …
Regular intake of NSAIDs reduces breast cancer risk
USA - Non-steroidal anti-inflammatory drugs (NSAIDs) could reduce the risk for breast cancer by 71%, according to recent studies published in the journal BMC Cancer. In colorectal Read more …
$430.3 billion global spend on drugs
Global sales of prescription and over-the-counter drugs grew 8% to $430.3 billion last year, according to the annual IMS World Review report, which tracks about 90% of all Read more …
Antibiotics for Africa and Latin America
A donation of the antibiotic Cipro® (Bayer HealthCare) with a wholesale value of more than US$ 25 million has been given to the non-profit organization MAP (Medical Assistance Read more …
Breast cancer
Five years of therapy with the drug tamoxifen has become the norm for postmenopausal women with hormone-sensitive breast cancer. However, this has several adverse side effects, Read more …
Simpler safer pill slicing
Patients with swallowing difficulties could benefit from the new version of the exakt S Tablet Splitter.
Read more …
Synchronising drug and gene therapies
Cancer can be tackled with a combination of drug and genetic therapies, so that the effectiveness of individual treatments are enhanced.
Read more …
Devlin respond to growing demand in Europe for infection control products, offering their “CleanKey” infection control keyboard in a variety of European languages. …
Knowing that good hygiene practice is critical to the prevention of cross contamination, New Style Healthcare services are introducing a range of unique hospital furniture to the …
To fight hospital infections and increasingly resistant bacteria Normeditec has developed Toul Mobile Laminar Airflow …
bioMérieux, a world leader in the field of in vitro diagnostics (IVD), offers the most comprehensive diagnostic solution on the market to help hospitals and healthcare …